Search

everythinglearnresearchcommunity

for

Search:↓

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Skin irritants can promote hair growth by affecting specific skin proteins.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Gorab deficiency speeds up skin aging by disrupting protein regulation and reducing collagen.

PICAT is a reliable tool for assessing dermatology residents' skills in PRP procedures for hair loss.

PRP treatment lacks strong evidence for routine use due to poor study quality.

Angio PRP speeds up skin wound healing by improving cell growth and blood vessel formation.

Platelet-rich plasma can help grow more and longer hair by creating new blood vessels.

Dickkopf-related Protein 2 can help hair grow by activating a specific cell pathway.

Platelet-rich plasma can effectively treat and prevent tissue infections.

SKO-derived SKP-like cells may help with hair regeneration and skin restoration.

Platelet-rich plasma may help with wound healing, hair growth, and skin rejuvenation, but more research is needed to prove its effectiveness.

Standardized PRP therapy can improve treatment for hair loss.

Recognizing keratosis pilaris in all skin tones helps diagnose related skin issues and reduce distress.

Kerion is a severe scalp infection that needs quick treatment to avoid permanent hair loss in children.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

PAR-1 may play a role in hair growth regulation in human hair follicles.

Mutations in the AP1B1 gene cause a new syndrome with skin, hearing, and developmental issues.

Certain genetic changes in the KRT82 gene may cause patchy skin in New Zealand rabbits.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

QLT0267 stops hair follicle cell growth and movement.

PRF is promising for dental and aesthetic uses but needs more research.

Rac1 is crucial for normal hair structure and pigmentation.

Dermatologists should consider congenital syndromes like TRPS in young adults with early hair loss.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

AA-PRP injections significantly promote hair growth but need better study design for clear efficacy.